Skip to main content
  • Sign in
  • Help
BOPA
  • Why join BOPA
  • Pricing
  • Education
    • BOPA Introduction to Cancer Course 2025
    • Courses and eLearning
    • SACT Verification Hub (Passport)
    • Resource Library
    • Cancer Hub
    • Education & Training Standards
    • Let’s Talk About SACT – a BOPA Podcast
  • About BOPA
    • About BOPA
    • Welcome to BOPA
    • Executive Committee
    • Subcommittees & working groups
    • Affiliated Groups
    • Specialist Advisory Groups
    • International Groups
    • BOPA Fellows
    • Corporate Membership
    • BOPA membership FAQs
  • Conference
    • Latest Conference 2025
    • Abstract Submission Opens 31st March
    • Past Symposiums / Conferences
  • News & Events
    • News
    • Events calendar
    • Submit event
  • Menu iconLCC
    • LCC
    • Cancer Hub
  • Join BOPA
Join BOPA
BOPA Join BOPA
  • Why join BOPA
  • Pricing
  • Education
    • BOPA Introduction to Cancer Course 2025
    • Courses and eLearning
    • SACT Verification Hub (Passport)
    • Resource Library
    • Cancer Hub
    • Education & Training Standards
    • Let’s Talk About SACT – a BOPA Podcast
  • About BOPA
    • About BOPA
    • Welcome to BOPA
    • Executive Committee
    • Subcommittees & working groups
    • Affiliated Groups
    • Specialist Advisory Groups
    • International Groups
    • BOPA Fellows
    • Corporate Membership
    • BOPA membership FAQs
  • Conference
    • Latest Conference 2025
    • Abstract Submission Opens 31st March
    • Past Symposiums / Conferences
  • News & Events
    • News
    • Events calendar
    • Submit event
  • Menu iconLCC
    • LCC
    • Cancer Hub
  • Join BOPA

Back to course

Jump to quiz

Introduction

You will now be assessed on what you have learnt during this module with a series of multiple choice questions:

  • Each question will have a time limit of 1 minute and you can see how much time remains by the clock on the right hand side of the page
  • Click on your chosen answer and click “Next” at the bottom of the page to work your way through the questions
  • Once an option has been selected, your answer cannot be changed
  • You will only have one chance to complete the assessment
  • You will have access to the correct set of answers and additional resources for the module at the end.

Good Luck!

Time limit: 0

Quiz Summary

0 of 10 Questions completed

Questions:

Information

You have already completed the quiz before. Hence you can not start it again.

Quiz is loading…

You must sign in or sign up to start the quiz.

You must first complete the following:

Results

Quiz complete. Results are being recorded.

Results

0 of 10 Questions answered correctly

Your time:

Time has elapsed

You have reached 0 of 0 point(s), (0)

Earned Point(s): 0 of 0, (0)
0 Essay(s) Pending (Possible Point(s): 0)

Categories

  1. Not categorized 0%
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  1. Current
  2. Review
  3. Answered
  4. Correct
  5. Incorrect
  1. Question 1 of 10
    1. Question

    Question 1 of 10

    How many recognised ‘hallmarks of cancer’ are there?

  2. Question 2 of 10
    2. Question

    Question 2 of 10

    How many DNA mutations are required for a cell to behave as a cancer cell?

  3. Question 3 of 10
    3. Question

    Question 3 of 10

    Which of the following statements about telomeres are true?

  4. Question 4 of 10
    4. Question

    Question 4 of 10

    What is the process that allows cancer cells to metastasize?

  5. Question 5 of 10
    5. Question

    Question 5 of 10

    Which of the following are tumour suppressor proteins?

  6. Question 6 of 10
    6. Question

    Question 6 of 10

    Which of the following are ways in which tumour cells can evade the immune system?

  7. Question 7 of 10
    7. Question

    Question 7 of 10

    By which mechanism do cancer cells generate energy?

  8. Question 8 of 10
    8. Question

    Question 8 of 10

    Match the drug to its target

    Sort elements
    • Vascular Endothelial Growth Factor Receptor Tyrosine Kinase
    • Epithelial Growth Factor Receptor
    • BRAF
    • Human Epithelial Growth Factor Receptor (HER2)
    • Programmed Death Receptor-1
    • mTOR
    • MEK
    • Sunitinib
      • Cetuximab
        • Dabrafenib
          • Trastuzumab
            • Nivolumab
              • Everolimus
                • Trametinib
                • Question 9 of 10
                  9. Question

                  Question 9 of 10

                  Which subtype of PI3K is commonly mutated in solid tumours?

                • Question 10 of 10
                  10. Question

                  Question 10 of 10

                  Select the correct statement relating to response to different treatment types

                  Sort elements
                  • high response rate + short duration of response
                  • higher response rate + improved duration of response
                  • low response rate + prolonged duration of response
                  • Cytotoxic chemotherapy
                    • Targeted treatments
                      • Checkpoint inhibitors
                      BOPA logo
                      • Why join BOPA
                      • Pricing/Join
                      • Conference 2024
                      • Education
                      • About
                      • News & Events
                      • Help
                      • Go to LinkedIn
                      • Go to Twitter
                      • Go to Facebook
                      • Go to Instagram
                      • Go to Bluesky

                      © Copyright 2025 British Oncology Pharmacy Association.
                      Registered Charity No. 1065026

                      • Privacy Policy
                      • T&Cs Website
                      • T&Cs Membership
                      • Cookies
                      • Contact
                      Designed and developed by Rouge
                      Our website uses cookies to distinguish you from other users of our website. This helps us to provide you with a good experience when you browse our website and also allows us to improve our site. By continuing to browse the site, you are agreeing to our use of cookies.